Works matching IS 17921074 AND DT 2023 AND VI 26 AND IP 2

Results: 43

Radionecrosis mimicking pseudo-progression in a patient with lung cancer and brain metastasis following the combination of anti-PD-1 therapy and stereotactic radiosurgery: A case report.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13947

By:

XIAOLIN JI;
LUXUAN WANG;
YANLI TAN;
YANHONG SHANG;
RAN HUO;
CHUAN FANG;
CHUNHUI LI;
LIJIAN ZHANG

Publication type:

Article

Exploration of novel clusters and prognostic value of immune-related signatures and identify HAMP as hub gene in colorectal cancer.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13946

By:

HONGYUAN WU;
HELING DONG;
SHAOFANG REN;
JIANXIN CHEN;
YAN ZHANG;
MENG DAI;
YINFEN WU;
XUEFANG ZHANG

Publication type:

Article

CD47 polymorphism for predicting nivolumab benefit in patients with advanced non-small-cell lung cancer.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13950

By:

TATSUYA OGIMOTO;
HIROAKI OZASA;
HIRONORI YOSHIDA;
TAKASHI NOMIZO;
TOMOKO FUNAZO;
HIROSHI YOSHIDA;
KENTARO HASHIMOTO;
KAZUTAKA HOSOYA;
MASATOSHI YAMAZOE;
HITOMI AJIMIZU;
TAKAHIRO TSUJI;
YUICHI SAKAMORI;
KIYOMITSU KUNINAGA;
SATOSHI MORITA;
TOYOHIRO HIRAI

Publication type:

Article

S100 proteins in head and neck squamous cell carcinoma (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13948

By:

YIHONG HU;
YUCHENG HAN;
MINHUI HE;
YANQUN ZHANG;
XIANQIONG ZOU

Publication type:

Article

RETRACTION.

Published in:: Oncology Letters, 2023, v. 26, n. 2, p. 382, doi. 10.3892/ol.2023.13949
Publication type:: Article

Combination therapy with antibody-drug conjugate RC48 (disitamab vedotin) and zimberelimab (PD-1 inhibitor) successfully controlled recurrent HER2-positive breast cancer resistant to trastuzumab emtansine: A case report.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13945

By:

SHANMIN FAN;
LIANXIANG HE;
DIE SANG

Publication type:

Article

Metabolomic analysis of gut metabolites in patients with colorectal cancer: Association with disease development and outcome.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13944

By:

ZHUFU XIE;
RUI ZHU;
XIAOYING HUANG;
FEI YAO;
SHU JIN;
QIYOU HUANG;
DEQUAN WANG;
HUAN LI;
QIANG WANG;
HUI LONG;
QINGMING WU

Publication type:

Article

Twist1-mediated transcriptional activation of Claudin-4 promotes cervical cancer cell migration and invasion.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13933

By:

CHAO LI;
HAIFENG LUO;
WENLI SONG;
YAN HU;
JINGJING LI;
ZHIQIANG CAI

Publication type:

Article

Lidocaine induces epithelial-mesenchymal transition and aggravates cancer behaviors in non-small cell lung cancer A549 cells.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13932

By:

WEN-HUI HSIEH;
SHU-WEI LIAO;
SHUN-MING CHAN;
JIN-DE HOU;
SZU-YUAN WU;
BING-YING HO;
KUNG-YEN CHEN;
YU-TING TAI;
HSU-WEI FANG;
CHIH-YUAN FANG;
SE-YI CHEN;
JUI-AN LIN

Publication type:

Article

RETRACTION.

Published in:: Oncology Letters, 2023, v. 26, n. 2, p. 216, doi. 10.3892/ol.2023.13931
Publication type:: Article

Deep convolutional neural network based on CT images of pulmonary nodules in the lungs of adolescent and young adult patients with osteosarcoma.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13930

By:

YUN LONG NI;
XIN CHENG ZHENG;
XIAO JIAN SHI;
YE FENG XU;
HUA LI

Publication type:

Article

SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13934

By:

LI-JUAN YE;
KAI-MIN XU;
GANG BAI;
JING YUAN;
FENG-MING RAN

Publication type:

Article

Severe cytopenia during adjuvant chemotherapy for early breast cancer in a patient with idiopathic CD4+ lymphocytopenia.

Published in:

2023

By:

KAITO MIMURA;
AKIHIKO SHIMOMURA;
KOJI WATANABE;
HANAKO KODA;
KANAKO NAKAYAMA;
DAI KITAGAWA;
CHIKAKO SHIMIZU

Publication type:

Case Study

Syndecan-1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13942

By:

AKCA, DUYGU;
SIMON, ADRIAN;
BUETTNER, REINHARD;
BRUNS, CHRISTIANE;
SCHROEDER, WOLFGANG;
ZANDER, THOMAS;
GEBAUER, FLORIAN;
QUAAS, ALEXANDER

Publication type:

Article

Novel single nucleotide polymorphism biomarkers to predict opioid effects for cancer pain.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13941

By:

YOSHIHIKO FUJITA;
HIROMICHI MATSUOKA;
YASUTAKA CHIBA;
JUNJI TSURUTANI;
TAKESHI YOSHIDA;
KIYOHIRO SAKAI;
MIKI NAKURA;
RYO SAKAMOTO;
CHIHIRO MAKIMURA;
YOICHI OHTAKE;
KAORU TANAKA;
HIDETOSHI HAYASHI;
MASAYUKI TAKEDA;
TATSUYA OKUNO;
NAOKI TAKEGAWA;
KOJI HARATANI;
TAKAYUKI TAKAHAMA;
JUNKO TANIZAKI;
ATSUKO KOYAMA;
KAZUTO NISHIO

Publication type:

Article

Intracorporeal linear-stapled gastroduodenostomy in totally laparoscopic distal gastrectomy for gastric cancer: Consideration of the intraoperative management of the duodenal wall between the transecting staple line and anastomotic staple line (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13940

By:

TAKAYA TOKUHARA;
EIJI NAKATA;
MASAYUKI HIGASHINO

Publication type:

Article

CLPTM1L expression predicts recurrence of patients with intermediate- and high-risk stage IB-IIB cervical cancer undergoing radical hysterectomy followed by TP as adjuvant chemotherapy.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13939

By:

YUICHIRO AWAZU;
TAKESHI FUKUDA;
TAKUYA NODA;
EIJIRO UCHIKURA;
SHIGENORI NANNO;
KENJI IMAI;
MAKOTO YAMAUCHI;
TOMOYO YASUI;
TOSHIYUKI SUMI

Publication type:

Article

RETRACTION.

Published in:: Oncology Letters, 2023, v. 26, n. 2, p. 286, doi. 10.3892/ol.2023.13938
Publication type:: Article

Efficacy and safety of envafolimab in the treatment of advanced dMMR/MSI-H solid tumors: A single-arm meta-analysis.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13937

By:

SHAOQING FAN;
CHUNYUE GAI;
BAOKUN LI;
GUIYING WANG

Publication type:

Article

Are there reliable multiparametric MRI criteria for differential diagnosis between intracranial meningiomas and solitary intracranial dural metastases?

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13936

By:

HONGJIE WU;
BEYLERLI, OZAL;
GAREEV, ILGIZ;
BEILERLI, AFERIN;
ILYASOVA, TATIANA;
TALYBOV, RUSTAM;
SUFIANOV, ALBERT;
XIAOLONG GUO

Publication type:

Article

Natural products as drug candidates for breast cancer (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13935

By:

TELANG, NITIN T.

Publication type:

Article

CRISPR/Cas9-mediated EZH2 knockout suppresses the proliferation and migration of triple-negative breast cancer cells.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13929

By:

Qiqi Mao;
Peibin Wu;
Haochen Li;
Xiaolan Fu;
Xuechen Gao;
Lei Yang

Publication type:

Article

Downregulation of VEGFR2 signaling by cedrol abrogates VEGF-driven angiogenesis and proliferation of glioblastoma cells through AKT/P70S6K and MAPK/ERK1/2 pathways.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13908

By:

KAI-FU CHANG;
CHE-YU LIU;
YA-CHIH HUANG;
CHIH-YEN HSIAO;
NU-MAN TSAI

Publication type:

Article

Glioblastoma with a primitive neuronal component: A case report.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13927

By:

QIANG MA;
LIMIN LIU;
NAIYING SUN;
LIXIANG GAO;
YING CHEN;
LI LIU;
WENJUN GUO;
XINGJIE YANG

Publication type:

Article

MicroRNA expression profiles associated with the metastatic ability of MDA-MB-231 breast cancer cells.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13926

By:

PHANNASIL, PHATCHARIYA;
AKEKAWATCHAI, CHAREEPORN;
JITRAPAKDEE, SARAWUT

Publication type:

Article

Long noncoding RNAs, glucose metabolism and cancer (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13925

By:

XIN-RUI HOU;
ZHEN-DONG ZHANG;
XIAO-LAN CAO;
XIAO-PING WANG

Publication type:

Article

Clinical features and treatment of bone marrow metastasis.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13918

By:

HONGLIANG YANG;
FENG HE;
TIAN YUAN;
WEN XU;
ZENG CAO

Publication type:

Article

Cytopenia after CAR-T cell therapy: Analysis of 63 patients with relapsed and refractory B-cell non-Hodgkin lymphoma.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13924

By:

TINGTING QIU;
LUAN HU;
YONGTIAN ZHANG;
YING WANG;
SHA MA;
DEPENG LI;
ZHENYU LI;
KAILIN XU

Publication type:

Article

Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13922

By:

YOSHIKO TSUJI;
TOMOAKI HARA;
SIKUN MENG;
HIROMICHI SATO;
YASUKO ARAO;
KEN OFUSA;
HIDESHI ISHII

Publication type:

Article

Twist1-mediated transcriptional activation of Claudin-4 promotes cervical cancer cell migration and invasion.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13921

By:

JIAQI ZHU;
QI JIANG

Publication type:

Article

A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13920

By:

MINEHIKO INOMATA;
YOSUKE KAWASHIMA;
RYOTA SAITO;
DAISUKE MORINAGA;
HITOMI NOGAWA;
MASAMICHI SATO;
YOHEI SUZUK;
SATORU YANAGISAWA;
TAKASHI KIKUCHI;
DAISUKE JINGU;
NARUO YOSHIMURA;
TOSHIYUKI HARADA;
EISAKU MIYAUCHI

Publication type:

Article

RETRACTION.

Published in:: Oncology Letters, 2023, v. 26, n. 2, p. 115, doi. 10.3892/ol.2023.13919
Publication type:: Article

Ocular and extraocular sebaceous carcinomas: A retrospective study with emphasis on the presence of in situ lesion and discussion and review of the histogenesis of extraocular sebaceous carcinoma.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13923

By:

DAISUKE TAKEUCHI;
MITSUAKI ISHIDA;
EMI YASUDA;
KOICHI UEDA;
YOSHINOBU HIROSE

Publication type:

Article

Long non-coding RNA PTCSC3 suppresses triple-negative breast cancer by downregulating long non-coding RNA MIR100HG.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13917

By:

GUOJUN ZHANG;
LEI GAO;
JUNLIANG ZHANG;
RUI WANG;
XIANGDONG WEI

Publication type:

Article

Safety of hypofractionated volumetric modulated arc therapy for early breast cancer: A preliminary report.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13916

By:

JEONG WON LEE;
MI JOO CHUNG

Publication type:

Article

Early low blood MALT1 expression levels forecast better efficacy of PD-1 inhibitor-based treatment in patients with metastatic colorectal cancer.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13915

By:

CHUANMING LI;
FAN YU;
WANLI XU

Publication type:

Article

Tumor organoid model of colorectal cancer (Review).

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13914

By:

CHI YANG;
WANGWEN XIAO;
RUI WANG;
YAN HU;
KE YI;
XUAN SUN;
GUANGHUI WANG;
XIAOHUI XU

Publication type:

Article

Luteolin induces apoptosis by impairing mitochondrial function and targeting the intrinsic apoptosis pathway in gastric cancer cells.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13913

By:

JUN MA;
ZHAOHAI PAN;
HONGCHAO DU;
XIAOJIE CHEN;
XUEJIE ZHU;
WENJIN HAO;
QIUSHENG ZHENG;
XUEXI TANG

Publication type:

Article

LGALS1 regulates cell adhesion to promote the progression of ovarian cancer.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13912

By:

XUEJIAN LI;
HUIFEI WANG;
ARAN JIA;
YUANYUAN CAO;
LIUQING YANG;
ZANHUI JIA

Publication type:

Article

MNX1 facilitates the malignant progress of lung adenocarcinoma through transcriptionally upregulating CCDC34.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13911

By:

JUNHUA WU;
CHONGMEI YUE;
WEIGUO XU;
HUI LI;
JING ZHU;
LIN LI

Publication type:

Article

Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13910

By:

AKIRA IIZUKA;
YASUTO AKIYAMA;
NAOKI SAKURA;
AKARI KANEMATSU;
YASUFUMI KIKUCHI;
TAKESHI NAGASHIMA;
KENICHI URAKAMI;
YUJI SHIMODA;
KEIICHI OHSHIMA;
AKIO SHIOMI;
YASUHISA OHDE;
MASANORI TERASHIMA;
KATSUHIKO UESAKA;
TAKASHI MUKAIGAWA;
YASUYUKI HIRASHIMA;
SHUSUKE YOSHIKAWA;
HIROHISA KATAGIRI;
TAKASHI SUGINO;
MITSURU TAKAHASHI;
HIROTSUGU KENMOTSU

Publication type:

Article

Low-dose anlotinib combined with EGFR-TKI can be used as an alternative for EGFR-TKI-resistant non-small cell lung cancer in elderly patients.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13909

By:

YI CHEN;
NANYUAN JIANG;
XIAO LIANG;
NAN CHEN;
YUN CHEN;
CHEN ZHANG;
JUNFENG SHI;
RENHUA GUO

Publication type:

Article

Combined use of a 980-nm diode laser and preoperative intravesical instillation of pirarubicin for the prevention of short-term recurrence of non-muscle invasive bladder cancer: A pilot study.

Published in:

Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13908

By:

Zhen Tang;
Jiao Peng;
Shangxin Wu;
Fenfen Zhao;
Mingui Wu

Publication type:

Article